Results 111 to 120 of about 14,058 (187)

Correction for Kharrat et al., The antimicrobial activity of ETD151 defensin is dictated by the presence of glycosphingolipids in the targeted organisms. [PDF]

Proc Natl Acad Sci U S A
europepmc   +1 more source

Region-specific quantitation of glycosphingolipids in the elderly human brain with Nanoflow MEA Chip Q/ToF mass spectrometry. [PDF]

Glycobiology
Schindler RL, Jin LW, Zivkovic AM, Liu Y, Lebrilla CB.   +4 more
europepmc   +1 more source

Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development. [PDF]

Front Pharmacol
Gómez-Cebrián N, Trull MC, Gras-Colomer E, Edo Solsona MD, Poveda Andrés JL, Puchades-Carrasco L.   +5 more
europepmc   +1 more source

The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis. [PDF]

Int J Mol Sci
Jennemann R, Sandhoff R.
europepmc   +1 more source

Pioneering microbial synthesis of gangliosides in the filamentous fungus Ashbya gossypii. [PDF]

Biotechnol Biofuels Bioprod
Montero-Bullón JF, Martín-González J, Ledesma-Amaro R, Jiménez A, Buey RM.   +4 more
europepmc   +1 more source

Multi-omic analysis reveals lipid dysregulation associated with mitochondrial dysfunction in parkinson's disease brain. [PDF]

Nat Commun
Hällqvist J, Toomey CE, Pinto R, Baldwin T, Doykov I, Wernick A, Al Shahrani M, Evans JR, Lachica J, Pope S, Heales S, Eaton S, Mills K, Gandhi S, Heywood WE.   +14 more
europepmc   +1 more source

How should kidney injury in Fabry disease be assessed and monitored? [PDF]

Kidney Res Clin Pract
Song SH.
europepmc   +1 more source

Ganglioside therapy in cancer molecular insights and therapeutic opportunities. [PDF]

Discov Oncol
Banerjee A, Banerjee S, Maity SR, Das A.
europepmc   +1 more source

Rethinking Metabolic Dysfunction in Chronic Liver Diseases. [PDF]

touchREV Endocrinol
Mak LL.
europepmc   +1 more source